Concept Foundation is governed by its Board of Directors, who provide institutional oversight and guidance and significant reproductive and maternal health experience to the organization on a voluntary basis.

Elizabeth Lule (Chair)

Elizabeth is currently an independent consultant and formerly the Director of Family Planning at the Bill and Melinda Gates Foundation.

Prior to this she spent 12 years at the World Bank and served in several senior positions including Director and Manager of the Africa Regional Integration Program, Manager of Operational Quality and Knowledge Services, Manager of the Africa multi-country HIV/AIDS Program and served for five years as the World Bank’s Senior Adviser for Population and Reproductive, Maternal and Child Health. Prior to joining the World Bank, Elizabeth was Africa Regional Vice President for Pathfinder International and before this worked with USAID in Nigeria.

She is a passionate leader and effective advocate on reproductive, maternal, child and adolescent health and committed to social justice to scale up interventions and technologies that reach poor and marginalised groups.

She has served on various Boards of Directors, think tanks and UN inter-agency task teams and was Adjunct Professor at Georgetown University for over five years. She has published widely on various issues on women and adolescent health, population and development, health reforms, and HIV/AIDS and is a frequent speaker in international and academic fora. She was the founding Chair of the Reproductive Health Supplies Coalition and founding member of the Partnership on Maternal, Newborn and Child Health. She has advanced degrees in Medical Demography jointly from the London School of Hygiene and Tropical Medicine and London School of Economics.

Lucky S. Slamet (Vice Chair)

Lucky Slamet graduated with Dra in Pharmacy and Apoteker from the University of Indonesia. She then achieved a Masters of Science specializing in Community Health and Pharmaco-Epidemiology studies from Queen’s University, Kingston, Canada.

From 1999 until 2000, she served as Head of Directorate of Drug Control at the DG of Drug and Food Control (DFC) Ministry of Health (MoH) and then as Director for Drug and Medical Devices Control in the DG of DFC MoH from 2000 to 2001.  From 2001 until 2012, she was appointed as  Deputy Head for Therapeutic Products and Narcotics, Psychotropics, and Hazardous Substances in the National Agency of Food and Drug Control (NAFDC) Indonesia. She subsequently served as Head of the NAFDC until her retirement in 2013. She is now serving as the adviser/technical consultant to the Head of NADFC, Indonesia.

During her career of more than 30 years as a government official, she has accumulated extensive professional experience in the field of medicine, including reproductive health products and vaccines, at national, regional and international levels. She was responsible for the availability of medicines and vaccines of assured quality, safety and efficacy in Indonesia. She was the vice-chair of the Drug Evaluation Committee from 2001 to 2012 and  the chair from 2012- 2013. She is currently involved in the Drug Evaluation Committee as an independent expert. She is also involved in the standardization of pharmaceuticals including vaccines in the development of the Indonesian Pharmacopeiea. She is the member of the Indonesian National Research Board (2013-2015), and the Indonesian Clinical Trial Working Group.

At the regional level, she participated in the ASEAN Pharmaceutical Product Working Group as head of the Indonesian delegation from 1999 to 2013, where she supported the Vaccine Chapter Initiative. She is involved in the assessment of the implementation of ASEAN Harmonization on Pharmaceutical under WHO-ASEAN Project in 2015.

From 2006 to 2009 she served as the Chairperson of Developing Country Vaccine Regulator Network (DCVRN) coordinated by the WHO. Her involvement in the WHO Expert Committee as member of ECBS (Expert Committee of Biological Standardization) since 2009, and member of ECSPP (Expert Committee on Specification for Pharmaceutical Preparations) since 2010, has been very useful not only for the development of international standards and guidelines for pharmaceuticals and vaccines but also for strengthening regulatory action in Indonesia. She is a member of the WHO Expert Committee on Drug Dependence in 2014. She serves as a WHO temporary adviser in many important conferences, and consultation meetings as well as trainers in WHO Global Learning Opportunity (GLO) in the field of Drug Evaluation and Clinical Trial Authorization. She is also recruited by the World Bank as a consultant in Management Drug Supply from 2013 (September) to 2015 (January) in Timor Leste.

Since 1998, she serves as an invited lecturer for Masters programs in National Drug Policy, Drug Supply Management and Pharmaco-Epidemiology in the leading National Indonesian University, such as Faculty of Pharmacy University of Indonesia; Faculty of Pharmacy and Study Center for Clinical Pharmacology and Drug Policy University of Gajah Mada, Indonesia.

Somchai Peerapakorn

Somchai Peerapakorn is a Thai field medical epidemiologist and a former World Health Organization staff.

Somchai earned his medical degree from Chulalongkorn University (1980), a certificate of the 2-year Thailand Field Epidemiology Training Programme (1984), and a Master’s degree on Public Health from Mahidol University (1985). In 1996 at the end of his 15-year government service, Somchai was the Director of Raj-Pracha-Samasai Institute, then the research unit of Thailand’s national leprosy control programme. From 1996 to 2012, he worked as an officer of the World Health Organization Country Office for Thailand, working with concerned parties for the successful planning, implementation, monitoring and evaluation of the Royal Thai Government-WHO collaborative programme, i.e. the WHO country programme for Thailand. He left WHO in June 2012 and has since become an independent consultant.

Currently (2018), Somchai advises Thailand Department of Disease Control on emerging and general communicable diseases, field epidemiology training, and urban disease control and prevention. He also advises the Ministry of Public Health on health service delivery systems in Bangkok Metropolitan area. He is the Director of Department of Disease Control Foundation, a local not-for-profit organization established to provide relevant managerial support to disease control missions and capacity building.

Helen Eskett

Helen resides in Christchurch, New Zealand, where she is the Principal of Helen Eskett & Associates, a practice providing financial and business advice, particularly to the health sector, for the past 25 years. She is also a joint owner and company director of a 30 unit tourist accommodation complex in Christchurch.

From 2005 to 2013 Helen served in the position of chair of a global procurement and commodities company, International Contraceptive & Reproductive Health Marketing Ltd (ICON), a subsidiary of the International Planned Parenthood Federation (IPPF) based in London. Her other international appointments included IPPF Global Treasurer (2005-2008) and IPPF Audit Chair (2001-2011). Both of these roles required strong governance to ensure financial stability for the Federation and to recognise risks and focus on their minimisation, over the 150 plus countries which form the global network. At a national level, Helen is a member of the Stand for Children board and she chairs the national finance and audit team.

She has also served the maximum term as President of the New Zealand Family Planning Association, which is where her passion for women’s reproductive health work grew and flourished. Access and choice for women are her paramount drivers.

Helen’s accounting background, community work and international experience have attributed to her desire and ability to work with governance, to draw boards and management together, enabling organisations to reach decisions and achieve their strategic goals.

Jeff Spieler

Jeff is currently a Consultant to USAID and several other organisations, as well as being an Advisor to the Board of the ICA Foundation and recently appointed to the Board of Trustees of the Population Council. He has 44 years of experience working internationally on contraceptive research and development, family planning research and service delivery, and reproductive health.

In December 2014 he retired (as a Contractor) from the position of Senior Technical Advisor for Science and Technology in Population and Reproductive Health (PRH) at USAID. Prior to his official retirement from USAID as a Federal Employee in October 2008, at USAID/PRH he was the Science Advisor (2007-2008), the Chief of the Research, Technology and Utilisation Division (1993-2007) and the Senior Biomedical Scientist (1983-1992).

Prior to joining USAID, Jeff spent 11 years as a Scientist in the Special Programme of Research, Development and Research Training in Human Reproduction at the WHO in Geneva, Switzerland and five years as a bench researcher at Lederle Laboratories in Pearl River, NY.

Jeff has a B.Sc. in Zoology from the University of Florida (1967), a M.Sc. in Zoological Sciences and Reproductive Biology from Rutgers University (1971), and was rewarded an Honorary Doctorate in Public Service from the University of Florida in 2002.

Pisake Lumbiganon

Pisake is a Professor of Obstetrics and gynecology, Convenor of Cochrane Thailand and Director of the WHO Collaborating Centre on Research Synthesis in Reproductive Health based at Faculty of Medicines, Khon Kaen University in Thailand. He is currently the President Elect of the Asia Ocenia Federation of Obstetrics and Gynecology.

He has published more than 150 papers including many Cochrane reviews in variouis international journals. Pisake was a dean in the Faculty of Medicines at Khon Kaen University from 2009 to 2013 and the President of the Royal Thai College of Obstetricians and Gynecologists from 2016 to 2018. In 2019, he received Honorable Fellowship from the Royal College of Obstetricians and Gynaecologists. His main areas of interest includes maternal and perinatal health, evidence based practises, sytematic review and meta-analysis.


Silke Lindenberg

Silke is currently an independent consultant and former Senior Marketing Executive at global pharmaceutical companies.

During her career of more than 30 years as Senior Marketing Executive, she has accumulated sound competences in the field of obstetrics & gynecology, diagnostics, intensive care equipment and enteral nutrition. Her main focus and passion has been in maternal health and obstetrics and gynecology for 11 years, where she lived in Switzerland. The leadership of a corporate social responsibility program between public and private stakeholders has driven her interest in public health and maternal health programs in low- and middle-income countries around the world. In her role, the advocacy work and strong communication programs within the pharmaceutical management have been essential. Additionally, overseeing financial and budget planning work was an essential part of her management role.

The establishment of a global program for young scientific leaders in maternal health has led to well recognized adboards and key opinion leader groups globally.

During her career in different international Marketing teams, Silke promoted a distinctively global approach. The identification of future needs, market trends and product innovations were critical elements. She led different commercial product launches including training and educational programs at pharmaceutical companies in Germany and Switzerland.

Prior to this she served 12 years as Marketing Manager and CEO in Diagnostics for infectious diseases, where Silke worked for one year in the Salt Lake City, US to lead a company divestment.

As biochemist she finished her PhD research work in the academic area of enzymatic glucose regulation at the university hospital in Hamburg, Germany. Additionally, she holds a degree in chemistry of food from the Hamburg university.

Currently Silke is working as consultant and is based near Frankfurt, Germany.


Luis Bahamondes

Professor of Gynaecology, Department of Obstetrics and Gynaecology, Faculty of Medical Sciences, University of Campinas, Campinas, SP, Brazil.

Professor of Gynaecology at the Department of Obstetrics and Gynaecology, University of Campinas Faculty of Medical Sciences, Campinas, SP, Brazil.

Luis Bahamondes obtained his medical degree at the Federal University of Cordoba, Argentina in 1971 and his PhD at the University of Campinas in 1982. 

In 1978 he obtained a position of assistant professor at the University of Campinas Faculty of Medical Sciences, Campinas, SP, Brazil and after that he occupied a position of Associate professor and later as a professor of Gynaecology since 2003.

He was consultant of many international organisations including JHPIEGO, the World Bank and the World Health Organisation. He was chairman of the Steering Committee of the Strategic Alliance of the WHO/HRP. He published more than 200 manuscripts in peer reviewed journals mainly on the topic of contraception, and currently is professor of the Post graduate course of the University of Campinas, as well as President of the Center for Research in Women Health of Campinas (CEMICAMP), an NGO associated to the University of Campinas.